Journal List > Tuberc Respir Dis > v.60(3) > 1000916

TOOLS
Kim and Chang: Respiratory Symptoms Relievers - Antitussives, Mucolytics, Antihistamines -
Review
Tuberculosis and Respiratory Diseases

Tuberculosis and Respiratory Diseases 2006; 60(3): 261-269.

Published online: 31 March 2006

DOI: https://doi.org/10.4046/trd.2006.60.3.261

Respiratory Symptoms Relievers - Antitussives, Mucolytics, Antihistamines -

Se Kyu Kim, M.D.1, 2, 3, Joon Chang, M.D.1, 2

1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

2The Institute of Chest Diseases, Yonsei University College of Medicine, Seoul, Korea.

3Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea.

Address for correspondence: Se Kyu Kim, M.D., Department of Internal Medicine, Yonsei University College of Medicine, 134 Shinchon-Dong, Seodaemun-Ku, Seoul 120-752, South Korea. Phone: 82-2-2228-1954, Fax: 82-2-393-6884, sekyukim@yumc.yonsei.ac.kr

Copyright © 2006 The Korean Academy of Tuberculosis and Respiratory Diseases

Figures and Tables

Table 1
Antitussives
trd-60-261-i001
Table 2
H1-receptor antagonists
trd-60-261-i002

References

1. Irwin RS, et al. Managing cough as a defense mechanisms and as a symptom: a consensus panel report of the American College of Chest Physicians. Chest. 1998. 114:Suppl. 133S–181S.
2. Jeon YJ. Chronic cough. Kor J Med. 2002. 63:118–125.
3. Irwin RS, Madison JM. The diagnosis and treatment of cough. N Engl J Med. 2000. 343:1715–1721.
4. Irwin RS, Madison JM. The persistently troublesome cough. Am J Resp Crit Care Med. 2002. 165:1469–1474.
5. Chang J. Common cold. Kor J Med. 1999. 56:778–780.
6. Chang J. Chronic cough. J Kor Med Assoc. 2002. 45:1331–1342.
7. Chang J. Cough. Kor J Med. 2002. 63:Suppl 2. S500–S512.
8. Yoon JH. Park IY, Yoon JH, Lee JG, Chung IH, editors. Human nasal mucosa histology. Clinical Anatomy of Nose. 2001. 1st ed. Seoul: Academia;32–56.
9. Quraishi MS, Jones NS, Mason J. The rheology of nasal mucus: a review. Clin Otolaryngol. 1998. 23:403–441.
10. Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: An update. Pharmacol Rev. 1998. 50:515–596.
11. van Ganse E, Kaufman L, Derde MO, et al. Effects of antihistamines in adult asthma: A meta-analysis of clinical trials. Eur Respir J. 1997. 10:2216–2224.
12. Spector SL, Nicodemus CF, Corren J, et al. Comparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma. J Allergy Clin Immunol. 1995. 96:174–181.
13. Busse WW, Middleton E, Storms W, et al. Corticosteroid-sparing effect of azelastine in the management of bronchial asthma. Am J Respir Crit Care Med. 1996. 153:122–127.
14. Poole PJ, Black PN. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2000. 2:CD001287.
15. Poole PJ, Black PN. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ. 2001. 322:1271.
16. Barnes PJ. Murray JF, Nadel JA, Mason RJ, Boushey HA, editors. Chapter 11. Airway pharmacology. Textbook of Respiratory Medicine. 2000. 3rd ed. W.B. Saunders Co;267–296.
17. You JH. Diagnosis and treatment of acute bronchitis The role of antitussives and mucolytics. Med Observer. 2005. 280:27.
18. Scadding G, Mitchell D. Albert RK, Spiro SG, Jett JR, editors. Chapter 28. Rhinitis and Sinusitis. Clinical Respiratory Medicine. 2004. 2nd ed. Mosby Co;347.
19. Hosoe H, Kaise T, Ohmori K, Isohama Y, Kai H, Takahama K, Miyata T. Mucolytic and antitussive effects of erdosteine. J Pharm Pharmacol. 1999. 51:959–966.
20. Oh MY. The Korean Academy of Asthma, Allergy and Clinical Immunology. Chapter 2. Types and mechanisms of hypersensitivity. Asthma and Allergic diseases. 2002. Koonja Publishing;13–16.
21. Yoon JH. The Korean Academy of Asthma, Allergy and Clinical Immunology. Chapter 11. Mucus. Asthma and Allergic diseases. 2002. Koonja Publishing;73–77.
22. Decramer M, Rutten-van Molken M, Dekhuijen PNR, Troosters T, van Herwaarden C, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCHUS): a randomized placebo-controlled trial. Lancet. 2005. 365:1552–1560.
TOOLS
Similar articles